Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 6074

1.

Measurable residual disease evaluated by flow cytometry using leukemia associated immune phenotypes following allogeneic stem cell transplantation is associated with high relapse rates in patients with acute myeloid leukemia.

Shimomura Y, Hara M, Maruoka H, Yabushita T, Ishikawa T.

Leuk Lymphoma. 2019 Nov 11:1-4. doi: 10.1080/10428194.2019.1686500. [Epub ahead of print] No abstract available.

PMID:
31710240
2.

Complete response of advanced hepatocellular carcinoma achieved by sorafenib dose re-escalation after failure of long-term low-dose-sorafenib treatment combined with transcatheter arterial chemoembolization: a case report.

Muto H, Kuzuya T, Ito T, Ishizu Y, Honda T, Ishikawa T, Ishigami M, Fujishiro M.

Clin J Gastroenterol. 2019 Nov 11. doi: 10.1007/s12328-019-01066-7. [Epub ahead of print]

PMID:
31709503
3.

Contribution of different adherent properties of Granulicatella adiacens and Abiotrophia defectiva to their associations with oral colonization and the risk of infective endocarditis.

Sasaki M, Shimoyama Y, Ishikawa T, Kodama Y, Tajika S, Kimura S.

J Oral Sci. 2019 Nov 9. doi: 10.2334/josnusd.19-0021. [Epub ahead of print]

PMID:
31708553
4.

15-Deoxy-Δ12,14-prostaglandin J2 ameliorates dextran sulfate sodium-induced colitis in mice through heme oxygenase-1 induction.

Takagi T, Naito Y, Mizuhima K, Hirai Y, Kamada K, Uchiyama K, Handa O, Ishikawa T, Itoh Y.

Arch Biochem Biophys. 2019 Nov 5:108183. doi: 10.1016/j.abb.2019.108183. [Epub ahead of print]

PMID:
31704099
5.

Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs.

Morii Y, Osawa T, Suzuki T, Shinohara N, Harabayashi T, Ishikawa T, Tanikawa T, Yamashina H, Ogasawara K.

BMC Urol. 2019 Nov 8;19(1):110. doi: 10.1186/s12894-019-0533-x.

6.

[Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].

Ishikawa T, Fukumi T, Moriyama T, Murakami H, Nagakita K, Yoshioka T, Makita M, Shinno Y, Sunami K.

Rinsho Ketsueki. 2019;60(10):1455-1461. doi: 10.11406/rinketsu.60.1455. Japanese.

PMID:
31695007
7.

[Improvement of autoimmune cytopenia with ibrutinib in a chronic lymphocytic leukemia patient complicated by monoclonal immunoglobulin deposition disease].

Nakamura M, Yoshioka S, Yamashita D, Hara S, Ishikawa T.

Rinsho Ketsueki. 2019;60(10):1449-1454. doi: 10.11406/rinketsu.60.1449. Japanese.

PMID:
31695006
8.

Cost-effectiveness of BRCA1/2 mutation profiling to target olaparib use in patients with metastatic breast cancer.

Saito S, Nakazawa K, Nagahashi M, Ishikawa T, Akazawa K.

Per Med. 2019 Nov 6. doi: 10.2217/pme-2018-0141. [Epub ahead of print]

PMID:
31692405
9.

Correlation of serum zinc levels with pathological and laboratory findings in patients with nonalcoholic fatty liver disease.

Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Toyoda H, Kumada T, Fujishiro M.

Eur J Gastroenterol Hepatol. 2019 Oct 30. doi: 10.1097/MEG.0000000000001587. [Epub ahead of print]

PMID:
31688305
10.

Heavy Water (D2O) Containing Preservation Solution Reduces Hepatic Cold Preservation and Reperfusion Injury in an Isolated Perfused Rat Liver (IPRL) Model.

Shimada S, Fukai M, Shibata K, Sakamoto S, Wakayama K, Ishikawa T, Kawamura N, Fujiyoshi M, Shimamura T, Taketomi A.

J Clin Med. 2019 Nov 1;8(11). pii: E1818. doi: 10.3390/jcm8111818.

11.

Parotid secretory carcinoma with high-grade transformation.

Numano Y, Ogawa T, Ishikawa T, Usubuchi H, Nakanome A, Ohkoshi A, Ishida E, Rokugo M, Katori Y.

Auris Nasus Larynx. 2019 Oct 31. pii: S0385-8146(19)30261-5. doi: 10.1016/j.anl.2019.10.003. [Epub ahead of print]

PMID:
31679811
12.

Dissection of the Superficial Temporal Artery: Significance and Performance with Bipolar Forceps.

Gutierrez-Avila O, Moroi J, Ishikawa T.

World Neurosurg. 2019 Oct 31. pii: S1878-8750(19)32773-1. doi: 10.1016/j.wneu.2019.10.145. [Epub ahead of print] No abstract available.

PMID:
31678315
13.

IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate.

Takano K, Saeki C, Oikawa T, Hidaka A, Mizuno Y, Ishida J, Takakura K, Nakano M, Torisu Y, Amano K, Ishikawa T, Zeniya M, Tsubota A, Saruta M.

J Gastroenterol Hepatol. 2019 Nov 1. doi: 10.1111/jgh.14900. [Epub ahead of print]

PMID:
31677185
14.

Trends in the Incidence of Sudden Deaths and Heart Diseases in Fukushima After the Great East Japan Earthquake.

Takiguchi M, Ohira T, Nakano H, Yumiya Y, Yamaki T, Yoshihisa A, Nakazato K, Suzuki H, Ishikawa T, Yasumura S, Kamiya K, Takeishi Y.

Int Heart J. 2019 Oct 31. doi: 10.1536/ihj.19-110. [Epub ahead of print]

15.

[Paroxysmal Atrial Fibrillation after Percutaneous Thrombectomy on Day 5 of Onset of Cerebral Embolism:A Case Report].

Sato N, Ishikawa T, Ebihara K, Endo K, Endo Y, Ota M.

No Shinkei Geka. 2019 Oct;47(10):1093-1100. doi: 10.11477/mf.1436204079. Japanese.

PMID:
31666427
16.

Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.

Kitakaze T, Yoshikawa M, Kobayashi Y, Kimura N, Goshima N, Ishikawa T, Ogata Y, Yamashita Y, Ashida H, Harada N, Yamaji R.

Biochim Biophys Acta Mol Cell Res. 2019 Oct 27:118563. doi: 10.1016/j.bbamcr.2019.118563. [Epub ahead of print]

PMID:
31666191
17.

Atrial reverse remodeling represented by the atrial conduction time in persistent atrial fibrillation patients after catheter ablation: its impact on predicting late atrial fibrillation recurrence.

Hori Y, Nakahara S, Fukuda R, Sato H, Ukaji T, Koshikawa Y, Nishiyama N, Ishikawa T, Kobayashi S, Taguchi I.

J Cardiol. 2019 Oct 27. pii: S0914-5087(19)30317-X. doi: 10.1016/j.jjcc.2019.09.018. [Epub ahead of print]

PMID:
31666177
18.

Investigation of the cumulative number of chromosome aberrations induced by three consecutive CT examinations in eight patients.

Abe Y, Noji H, Miura T, Sugai M, Kurosu Y, Ujiie R, Tsuyama N, Yanagi A, Yanai Y, Ohba T, Ishikawa T, Kamiya K, Yoshida MA, Sakai A.

J Radiat Res. 2019 Oct 28. pii: rrz068. doi: 10.1093/jrr/rrz068. [Epub ahead of print]

PMID:
31665444
19.

Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: a multicenter analysis with propensity score matching.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y; Real-life Practice Experts for HCC (RELPEC) Study Group and the HCC 48 Group (Hepatocellular carcinoma experts from 48 clinics in Japan).

Hepatol Res. 2019 Oct 29. doi: 10.1111/hepr.13427. [Epub ahead of print]

PMID:
31660700
20.

TAK-925, an orexin 2 receptor-selective agonist, shows robust wake-promoting effects in mice.

Yukitake H, Fujimoto T, Ishikawa T, Suzuki A, Shimizu Y, Rikimaru K, Ito M, Suzuki M, Kimura H.

Pharmacol Biochem Behav. 2019 Oct 22;187:172794. doi: 10.1016/j.pbb.2019.172794. [Epub ahead of print]

PMID:
31654653
21.

Potential utility of anti-TNF drugs in synovial chondromatosis associated with ankylosing spondylitis.

Yu S, Wu M, Zhou G, Ishikawa T, Liang J, Nallapothula D, Singh RR, Wang Q, Wang M.

Int J Rheum Dis. 2019 Oct 24. doi: 10.1111/1756-185X.13734. [Epub ahead of print]

PMID:
31647182
22.

Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study.

Ishikawa T, Yasuda T, Okayama T, Dohi O, Yoshida N, Kamada K, Uchiyama K, Takagi T, Konishi H, Shiozaki A, Fujiwara H, Konishi H, Naito Y, Teramukai S, Itoh Y.

Cancer Sci. 2019 Oct 23. doi: 10.1111/cas.14218. [Epub ahead of print]

23.

Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease.

Ohashi K, Ishikawa T, Hoshii A, Hokari T, Suzuki M, Mitobe Y, Yamada E, Abeywickrama HM, Kikuchi Y, Noguchi H, Hirosawa H, Koyama Y.

J Clin Med Res. 2019 Oct;11(10):711-719. doi: 10.14740/jocmr3978. Epub 2019 Oct 4.

24.

Dual-Phase Computed Tomography Angiography Enhances Detection of Contrast Extravasation in Subarachnoid Hemorrhage.

Suzuki K, Kurashima A, Abe K, Ishikawa T, Yamaguchi K, Kawamata T, Yaguchi A, Sakai S.

World Neurosurg. 2019 Oct 16. pii: S1878-8750(19)32664-6. doi: 10.1016/j.wneu.2019.10.046. [Epub ahead of print]

PMID:
31629136
25.

Anti-prion drug screening system in Saccharomyces cerevisiae based on an artificial [LEU2+] prion.

Ishikawa T, Lisiecki K.

Fungal Genet Biol. 2019 Oct 14;134:103280. doi: 10.1016/j.fgb.2019.103280. [Epub ahead of print]

PMID:
31622671
26.

Serum infliximab level in an infant delivered from a mother with psoriatic arthritis receiving infliximab.

Takeuchi S, Kamata M, Uchida H, Nagata M, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Ohnishi T, Tada Y.

J Dermatol. 2019 Oct 16. doi: 10.1111/1346-8138.15124. [Epub ahead of print] No abstract available.

PMID:
31621097
27.

Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial.

Fujisaki T, Ishikawa T, Takamatsu H, Suzuki K, Min CK, Lee JH, Wang J, Carson R, Crist W, Qi M, Nagafuji K.

Ann Hematol. 2019 Oct 16. doi: 10.1007/s00277-019-03794-9. [Epub ahead of print]

PMID:
31620815
28.

Syndromic surveillance using ambulance transfer data in Tokyo, Japan.

Sugishita Y, Sugawara T, Ohkusa Y, Ishikawa T, Yoshida M, Endo H.

J Infect Chemother. 2019 Oct 11. pii: S1341-321X(19)30283-1. doi: 10.1016/j.jiac.2019.09.011. [Epub ahead of print]

PMID:
31611069
29.

Real-world experience of 12-week DAA regimen of glecaprevir and pibrentasvir in patients with chronic HCV infection.

Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Tanaka Y, Iwakiri K, Kumada T.

J Gastroenterol Hepatol. 2019 Oct 14. doi: 10.1111/jgh.14874. [Epub ahead of print]

PMID:
31609495
30.

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis.

Numata T, Nakayama K, Utsumi H, Kobayashi K, Yanagisawa H, Hashimoto M, Minagawa S, Ishikawa T, Hara H, Araya J, Kuwano K.

BMC Pulm Med. 2019 Oct 12;19(1):176. doi: 10.1186/s12890-019-0952-1.

31.

Endoscopic ultrasonography for the evaluation of pancreatic cystic neoplasms.

Ohno E, Hirooka Y, Kawashima H, Ishikawa T, Fujishiro M.

J Med Ultrason (2001). 2019 Oct 11. doi: 10.1007/s10396-019-00980-0. [Epub ahead of print] Review.

PMID:
31605262
32.

Mechanism of Membrane Depolarization Involved in α1A-Adrenoceptor-Mediated Contraction in Rat Tail and Iliac Arteries.

Ishida H, Saito SY, Dohi N, Ishikawa T.

Biol Pharm Bull. 2019;42(10):1741-1745. doi: 10.1248/bpb.b19-00473.

33.

Differentiation-inducing factor-1 prevents hepatic stellate cell activation through inhibiting GSK3β inactivation.

Furukawa S, Yamaguchi M, Ooka A, Kikuchi H, Ishikawa T, Saito SY.

Biochem Biophys Res Commun. 2019 Nov 26;520(1):140-144. doi: 10.1016/j.bbrc.2019.09.117. Epub 2019 Sep 30.

PMID:
31582219
34.

Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.

Sakakida T, Ishikawa T, Chihara Y, Harita S, Uchino J, Tabuchi Y, Komori S, Asai J, Narukawa T, Arai A, Tsunezuka H, Kosuga T, Konishi H, Moriguchi M, Yasuda H, Hongo F, Inoue M, Hirano S, Ukimura O, Itoh Y, Taguchi T, Takayama K.

Clin Transl Oncol. 2019 Oct 1. doi: 10.1007/s12094-019-02214-8. [Epub ahead of print]

PMID:
31576495
35.

Real-world single-center experience with ten cases of generalized pustular psoriasis successfully treated with ixekizumab.

Nagata M, Kamata M, Fukaya S, Hayashi K, Fukuyasu A, Tanaka T, Ishikawa T, Ohnishi T, Sugiura K, Tada Y.

J Am Acad Dermatol. 2019 Sep 24. pii: S0190-9622(19)32785-9. doi: 10.1016/j.jaad.2019.09.040. [Epub ahead of print]

PMID:
31560979
36.

A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification.

Ishikawa T, Sasaki R, Nishimura T, Aibe Y, Saeki I, Iwamoto T, Hidaka I, Takami T, Sakaida I.

PLoS One. 2019 Sep 26;14(9):e0223153. doi: 10.1371/journal.pone.0223153. eCollection 2019.

37.

Intercellular IgA dermatosis aggravated during pregnancy.

Ishikawa T, Munetsugu T, Shinada Y, Yonekura Y, Fujimoto N, Ishii N, Hashimoto T, Satoh T.

Eur J Dermatol. 2019 Sep 25. doi: 10.1684/ejd.2019.3620. [Epub ahead of print] No abstract available.

PMID:
31556875
38.

Equatorial Pacific seawater pCO2 variability since the last glacial period.

Kubota K, Yokoyama Y, Ishikawa T, Sagawa T, Ikehara M, Yamazaki T.

Sci Rep. 2019 Sep 25;9(1):13814. doi: 10.1038/s41598-019-49739-0.

39.

Effects of different oral instructions on kinematic and kinetic parameters during drop vertical jump.

Yokoyama H, Oda A, Makino M, Ishikawa T, Shikanai K, Tsukamoto T, Tsuda E.

J Phys Ther Sci. 2019 Aug;31(8):670-674. doi: 10.1589/jpts.31.670. Epub 2019 Aug 9.

40.

R3hdml regulates satellite cell proliferation and differentiation.

Sakamoto K, Furuichi Y, Yamamoto M, Takahashi M, Akimoto Y, Ishikawa T, Shimizu T, Fujimoto M, Takada-Watanabe A, Hayashi A, Mita Y, Manabe Y, Fujii NL, Ishibashi R, Maezawa Y, Betsholtz C, Yokote K, Takemoto M.

EMBO Rep. 2019 Nov 5;20(11):e47957. doi: 10.15252/embr.201947957. Epub 2019 Sep 16.

PMID:
31524320
41.

Usefulness of real-time elastography for diagnosing lymph node metastasis of skin cancer; does elastography potentially eliminate the need for sentinel lymph node biopsy in squamous cell carcinoma?

Tanaka T, Kamata M, Fukaya S, Hayashi K, Fukuyasu A, Ishikawa T, Ohnishi T, Tada Y.

J Eur Acad Dermatol Venereol. 2019 Sep 14. doi: 10.1111/jdv.15955. [Epub ahead of print]

PMID:
31520558
42.

Ultrafast isomerization-induced cooperative motions to higher molecular orientation in smectic liquid-crystalline azobenzene molecules.

Hada M, Yamaguchi D, Ishikawa T, Sawa T, Tsuruta K, Ishikawa K, Koshihara SY, Hayashi Y, Kato T.

Nat Commun. 2019 Sep 13;10(1):4159. doi: 10.1038/s41467-019-12116-6.

43.

sRAGE Concentration İncreases Following the Treatment of Severe Diabetic Ketoacidosis

Hoffman WH, Ishikawa T, Blum J, Tani N, Ikeda T, Artlett CM.

J Clin Res Pediatr Endocrinol. 2019 Sep 13. doi: 10.4274/jcrpe.galenos.2019.2019.0076. [Epub ahead of print]

44.

Non-canonical Expression of Cardiac Troponin-T in Neuroendocrine Ethmoid Sinus Carcinoma Following Immune Checkpoint Blockade.

Tsuruda T, Sato Y, Kajihara K, Kawabata T, Kubuki Y, Komaki S, Kikuchi M, Ishikawa T, Tono T, Kitamura K.

Front Cardiovasc Med. 2019 Aug 23;6:124. doi: 10.3389/fcvm.2019.00124. eCollection 2019.

45.

Glycosylinositol phosphoceramide-specific phospholipase D activity catalyzes transphosphatidylation.

Hasi RY, Miyagi M, Morito K, Ishikawa T, Kawai-Yamada M, Imai H, Fukuta T, Kogure K, Kanemaru K, Hayashi J, Kawakami R, Tanaka T.

J Biochem. 2019 Nov 1;166(5):441-448. doi: 10.1093/jb/mvz056.

PMID:
31504617
46.

Comparing the spatial coherence of the natural and focused X-rays from a free electron laser.

Cho D, Yang J, Kim SS, Nam D, Park J, Kim S, Tono K, Yabashi M, Ishikawa T, Song C.

Opt Express. 2019 Jul 8;27(14):19573-19582. doi: 10.1364/OE.27.019573.

PMID:
31503715
47.

Forecasting maldistribution of human resources for healthcare and patients in Japan: a utilization-based approach.

Ishikawa T, Nakao Y, Fujiwara K, Suzuki T, Tsuji S, Ogasawara K.

BMC Health Serv Res. 2019 Sep 9;19(1):653. doi: 10.1186/s12913-019-4470-x.

48.

Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study.

Arai S, Ishikawa T, Kato H, Koshizaka M, Maezawa Y, Nakamura T, Suzuki T, Yokote K, Ishii I.

J Pharm Health Care Sci. 2019 Sep 2;5:20. doi: 10.1186/s40780-019-0150-6. eCollection 2019.

49.

Photophysics and Inverted Solvatochromism of 7,7,8,8-Tetracyanoquinodimethane (TCNQ).

Tamaya H, Torii Y, Ishikawa T, Nakano H, Iimori T.

Chemphyschem. 2019 Oct 2;20(19):2531-2538. doi: 10.1002/cphc.201900681. Epub 2019 Sep 2.

PMID:
31475788
50.

Fabrication of Zero-Order Sustained-Release Floating Tablets via Fused Depositing Modeling 3D Printer.

Kimura SI, Ishikawa T, Iwao Y, Itai S, Kondo H.

Chem Pharm Bull (Tokyo). 2019;67(9):992-999. doi: 10.1248/cpb.c19-00290.

Supplemental Content

Loading ...
Support Center